In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
How to use biomarkers to optimize diagnosis, prognosis and treatment of acute coronary syndrome
Session

Event : ESC Congress 2014

Topic : Non-ST-Elevation Myocardial Infarction (NSTEMI)

  • Session type : Satellite Symposium
  • Date : 01 September 2014
  • Time : 15:00 - 15:45
  • Sponsored by Roche Diagnostics

3 presentations in this session

The benefits of high-sensitive cardiac Troponin T for the early diagnosis of acute myocardial infarction.

Event : ESC Congress 2014

  • Session : How to use biomarkers to optimize diagnosis, prognosis and treatment of acute coronary syndrome
  • Speaker : CE Mueller (Basel,CH)
  • Sponsored by Roche Diagnostics

The prognostic and clinical utility of NT-proBNP and high-sensitive cardiac Troponin T after myocardial infarction .

Event : ESC Congress 2014

  • Session : How to use biomarkers to optimize diagnosis, prognosis and treatment of acute coronary syndrome
  • Speaker : H White (Auckland,NZ)
  • Sponsored by Roche Diagnostics

Innovative ways of de-escalating antiplatelet treatment in ACS patients: TROPICAL-ACS and beyond.

Event : ESC Congress 2014

  • Session : How to use biomarkers to optimize diagnosis, prognosis and treatment of acute coronary syndrome
  • Speaker : D Sibbing (Eichenau,DE)
  • Sponsored by Roche Diagnostics

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are